For: | Chen J, Dong JT, Li XJ, Gu Y, Cheng ZJ, Cai YK. Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats. World J Gastroenterol 2015; 21(2): 484-490 [PMID: 25593463 DOI: 10.3748/wjg.v21.i2.484] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i2/484.htm |
Number | Citing Articles |
1 |
Na Wang, Qing Han, Gai Wang, Wei-Ping Ma, Jia Wang, Wen-Xin Wu, Yu Guo, Li Liu, Xiao-Yu Jiang, Xiao-Li Xie, Hui-Qing Jiang. Resveratrol Protects Oxidative Stress-Induced Intestinal Epithelial Barrier Dysfunction by Upregulating Heme Oxygenase-1 Expression. Digestive Diseases and Sciences 2016; 61(9): 2522 doi: 10.1007/s10620-016-4184-4
|
2 |
Lihua Duan, Xiaoquan Rao, Zachary Braunstein, Amelia C. Toomey, Jixin Zhong. Role of Incretin Axis in Inflammatory Bowel Disease. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.01734
|
3 |
J.J. Worthington, F. Reimann, F.M. Gribble. Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity. Mucosal Immunology 2018; 11(1): 3 doi: 10.1038/mi.2017.73
|
4 |
Maria Schou Ebbesen, Hannelouise Kissow, Bolette Hartmann, Kathrine Grell, Jette Sønderskov Gørløv, Katrine Kielsen, Jens Juul Holst, Klaus Müller. Glucagon-Like Peptide-1 Is a Marker of Systemic Inflammation in Patients Treated with High-Dose Chemotherapy and Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2019; 25(6): 1085 doi: 10.1016/j.bbmt.2019.01.036
|
5 |
Priyankar Dey. Targeting gut barrier dysfunction with phytotherapies: Effective strategy against chronic diseases. Pharmacological Research 2020; 161: 105135 doi: 10.1016/j.phrs.2020.105135
|
6 |
Dipak Kumar Sahoo, Romy M. Heilmann, Biswaranjan Paital, Ashish Patel, Virendra Kumar Yadav, David Wong, Albert E. Jergens. Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1217165
|
7 |
Guifang Deng, Qiucheng Lei, Xuejin Gao, Yupeng Zhang, Huazhen Zheng, Jingcheng Bi, Xinying Wang. Glucagon-Like Peptide-2 Modulates Enteric Paneth Cells Immune Response and Alleviates Gut Inflammation During Intravenous Fluid Infusion in Mice With a Central Catheter. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.688715
|
8 |
Fusayo Io, Emi Gunji, Hiroko Koretsune, Koji Kato, Mami Sugisaki-Kitano, Lisa Okumura-Kitajima, Kayo Kimura, Saeko Uchida, Koji Yamamoto. SGL5213, a novel and potent intestinal SGLT1 inhibitor, suppresses intestinal glucose absorption and enhances plasma GLP-1 and GLP-2 secretion in rats. European Journal of Pharmacology 2019; 853: 136 doi: 10.1016/j.ejphar.2019.03.023
|
9 |
E.E. Connor, C.M. Evock-Clover, E.H. Wall, R.L. Baldwin, M. Santin-Duran, T.H. Elsasser, D.M. Bravo. Glucagon-like peptide 2 and its beneficial effects on gut function and health in production animals. Domestic Animal Endocrinology 2016; 56: S56 doi: 10.1016/j.domaniend.2015.11.008
|
10 |
Rasmus Hytting-Andreasen, Emilie Balk-Møller, Bolette Hartmann, Jens Pedersen, Johanne Agerlin Windeløv, Jens Juul Holst, Hannelouise Kissow, Giovanni Di Pasquale. Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice. PLOS ONE 2018; 13(6): e0198046 doi: 10.1371/journal.pone.0198046
|
11 |
Qiucheng Lei, Jingcheng Bi, Huanwei Chen, Feng Tian, Xuejin Gao, Ning Li, Xinying Wang. Glucagon-like peptide-2 improves intestinal immune function and diminishes bacterial translocation in a mouse model of parenteral nutrition. Nutrition Research 2018; 49: 56 doi: 10.1016/j.nutres.2017.10.007
|
12 |
Jing Han, Caiyu Li, Zhi Dai, Juanhui Duan, Wen Cai, Yong Wang, Youcai Zhang. Yinzhihuang Oral Liquid Ameliorates Hyperbilirubinemia Induced by δ‐Aminolevulinic Acid and Novobiocin in Neonatal Rats. Chemistry & Biodiversity 2021; 18(8) doi: 10.1002/cbdv.202100222
|
13 |
Marina Fortea, Mercé Albert-Bayo, Mar Abril-Gil, John-Peter Ganda Mall, Xavier Serra-Ruiz, Alejandro Henao-Paez, Elba Expósito, Ana María González-Castro, Danila Guagnozzi, Beatriz Lobo, Carmen Alonso-Cotoner, Javier Santos. Present and Future Therapeutic Approaches to Barrier Dysfunction. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.718093
|